๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Genetically Engineered Tumor Cell Vaccine in a Head and Neck Cancer Model

โœ Scribed by Marion Couch; John K. Saunders; Bert W. O'Malley Jr.,; Drew Pardoll; Elizabeth Jaffee


Book ID
110084307
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
214 KB
Volume
113
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Protein signatures associated with tumor
โœ Onno B. Bleijerveld; Ruud H. Brakenhoff; Tieneke B.M. Schaaij-Visser; J. Mirjam ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier ๐ŸŒ English โš– 871 KB

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer worldwide. Strong prognostic indicators that predict development of distant metastases are the presence and number of lymph node metastases in the neck, and extranodal spread. Recently, it was shown in several stu

T-cell markers in tumor-infiltrating lym
โœ Dr. Carl H. Snyderman; D. S. Heo; K. Chen; Theresa L. Whiteside; Jonas T. Johnso ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 575 KB

Fresh suspensions of tumor-infiltrating lymphocytes (TIL) from 16 patients with squamous cell carcinoma of the head and neck (SCCHN) were examined for T-cell markers including CD4 (helper-inducer), CD8 (cytotoxic-suppressor), natural killer (NK) cell, and activation surface markers using monoclonal